Skip to content

Comparing the effect of Triphala Ghrut and Mahatriphaladya Ghrut eye drops in patients with allergic conjunctivitis

COMPARATIVE CLINICAL TRIAL TO EVALUATE THE EFFICACY OF TRIPHALA GHRUT ASHCHYOTAN AND MAHATRIPHALADYA GHRUT ASHCHYOTAN IN THE MANAGEMENT OF VATAJ ABHISHYANDA W.S.R TO SIMPLE ALLERGIC CONJUNCTIVITIS - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108122
Enrollment
90
Registered
2026-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Sponsors

Dr Komal Bapu Shelke
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1Patients who are ready to sign informed consent form 2Age group of 18 to 50 years will be included in the study 3Patient suffering from at least 3 to 4 symptoms of Vataj Abhishyanda i.e 1 Nistoda (Pricking sensation in eyes) 2 Vishushkabhava (Feeling of Dryness in eyes) 3 Shishirashruta (Lacrimation of eyes ) 4 Kandu (Itching of eyes) 5 Sangharsha (foreign body sensation of eyes) 6 Ragata (Readness of eyes) 7 Daha (Burning sensation of eyes)

Exclusion criteria

Exclusion criteria: K/C/O Patient with any other ocular pathology like Bacterial conjunctivitis, keratoconjunctivitis sicca, verneral keratoconjunctivitis, giant papillary conjunctivitis, atopic conjunctivitis, corneal opacity, corneal ulcer, Malignancy, Immunosuppressive disorder. 2. K/C/O Patients with complicated dacryocystitis and all types of conjunctivitis which are non allergic in nature.

Design outcomes

Primary

MeasureTime frame
Reduction in sign and symptoms of vataj Abhishyanda such as reduction in nistod,vishushkabhav,shishirashruta,kandu,sangarsha,ragata,dahaTimepoint: Total duration of study-18 months Duration of treatment-1 week Assessment on 1st and 7th day

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Rekha Jori

Sangam Sevabhavi Trust

drrekhamatkar1912@gmail.com9503197787

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026